Novo Nordisk’s Older Generation Weight-Loss Drug Saxenda Associated With Decreased Bone Mass Density, Study Shows
Estimated read time 1 min read
Posted in Health Trends Health Trends - Canada

Novo Nordisk’s Older Generation Weight-Loss Drug Saxenda Associated With Decreased Bone Mass Density, Study Shows

admin

Novo Nordisk’s Older Generation Weight-Loss Drug Saxenda Associated With Decreased Bone Mass Density, Study Shows

In a new study published in the JAMA Network Open medical journal, Novo Nordisk A/S’s (NYSE:NVO) Saxenda (liraglutide), an earlier-generation weight loss drug, reveals significant…

[ad_2]

Source link

You May Also Like

More From Author

Boston scientists create AI model to ‘catch Alzheimer’s disease early’

Boston scientists create AI model to ‘catch Alzheimer’s disease early’

Half of India’s population physically unfit, says Lancet study | Health and Wellness News

Half of India’s population physically unfit, says Lancet study | Health and Wellness News

Leave a Reply

Your email address will not be published. Required fields are marked *